• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体在染色质上的长时间负载以及p160共激活因子的有效募集有助于前列腺癌细胞的雄激素非依赖性生长。

Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.

作者信息

Shi Xu-Bao, Xue Lingru, Zou June X, Gandour-Edwards Regina, Chen Hongwu, deVere White Ralph W

机构信息

Department of Urology, University of California, Davis, School of Medicine, Sacramento, California 95817, USA.

出版信息

Prostate. 2008 Dec 1;68(16):1816-26. doi: 10.1002/pros.20849.

DOI:10.1002/pros.20849
PMID:18780293
Abstract

BACKGROUND

Growth of most ablation-resistant prostate cancers (CaPs) is dependent on androgen receptor (AR) activity in chromatin, but cancer cells in these tumors have acquired altered AR activation. It is unclear how the aberrantly activated AR loads onto regulatory regions of AR-targeted genes. The purpose of this study was to assess the AR chromatin loading in an androgen-depleted environment.

METHODS

The expression of PSA in androgen-resistant CaP cells was determined using RT-PCR and Western blot analysis. In order to investigate the binding of the AR to the PSA gene regulatory regions, chromatin immunoprecipitation (ChIP) was performed in the androgen-independent cds2 cell line in the presence or absence of androgens. In addition, we examined the involvement of p160 coactivators in the chromatin loading of the AR.

RESULTS

It was found that constitutive activation of PSA expression was the result of sustained occupancy by the AR at the regulatory region of this gene. This stable AR loading was not blocked by the AR antagonist bicalutamide. Furthermore, androgen-resistant CaP cells highly expressed both AR and the p160 coactivators and the AR was able to recruit TIF2. Downregulation of TIF2 using short hairpin RNA disrupted the AR loading to the PSA enhancer and subsequently inhibited AR activity.

CONCLUSION

Prolonged AR localization to the regulatory regions of AR targeted genes and the recruitment of p160 coactivators are a potential mechanism leading to androgen-independent activation of the AR. Disruption of AR chromatin loading could therefore become an important therapeutic target for this disease.

摘要

背景

大多数抗消融前列腺癌(CaP)的生长依赖于染色质中的雄激素受体(AR)活性,但这些肿瘤中的癌细胞已出现AR激活改变。尚不清楚异常激活的AR如何加载到AR靶向基因的调控区域。本研究的目的是评估雄激素耗竭环境下的AR染色质加载情况。

方法

使用逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析确定雄激素抵抗性CaP细胞中前列腺特异性抗原(PSA)的表达。为了研究AR与PSA基因调控区域的结合情况,在有无雄激素存在的情况下,对雄激素非依赖性cds2细胞系进行染色质免疫沉淀(ChIP)。此外,我们研究了p160共激活因子在AR染色质加载中的作用。

结果

发现PSA表达的组成性激活是AR持续占据该基因调控区域的结果。这种稳定的AR加载不受AR拮抗剂比卡鲁胺的阻断。此外,雄激素抵抗性CaP细胞中AR和p160共激活因子均高表达,且AR能够募集转录中介因子2(TIF2)。使用短发夹RNA下调TIF2可破坏AR向PSA增强子的加载,随后抑制AR活性。

结论

AR在AR靶向基因调控区域的长期定位以及p160共激活因子的募集是导致AR雄激素非依赖性激活的潜在机制。因此,破坏AR染色质加载可能成为该疾病的重要治疗靶点。

相似文献

1
Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.雄激素受体在染色质上的长时间负载以及p160共激活因子的有效募集有助于前列腺癌细胞的雄激素非依赖性生长。
Prostate. 2008 Dec 1;68(16):1816-26. doi: 10.1002/pros.20849.
2
Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.雄激素受体拮抗剂比卡鲁胺在前列腺癌细胞中的活性独立于NCoR和SMRT共抑制因子。
Cancer Res. 2007 Sep 1;67(17):8388-95. doi: 10.1158/0008-5472.CAN-07-0617.
3
Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.共调节因子募集与雄激素受体在转录调控中的组蛋白修饰
Mol Endocrinol. 2004 Nov;18(11):2633-48. doi: 10.1210/me.2004-0245. Epub 2004 Aug 12.
4
Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.二甲双胍通过靶向雄激素受体抑制雄激素依赖性和非雄激素依赖性前列腺癌。
Prostate. 2015 Aug 1;75(11):1187-96. doi: 10.1002/pros.23000. Epub 2015 Apr 20.
5
Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.Zyflamend 抑制雄激素受体的表达和功能,并与比卡鲁胺协同抑制前列腺癌细胞生长。
Prostate. 2012 Feb;72(3):244-52. doi: 10.1002/pros.21426. Epub 2011 Jun 8.
6
A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.一种竞争性抑制剂,可减少雄激素受体向雄激素反应基因的募集。
J Biol Chem. 2012 Jul 6;287(28):23368-80. doi: 10.1074/jbc.M112.344671. Epub 2012 May 15.
7
Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.长期使用阿扎胞苷治疗会产生分化作用,使去势抵抗性前列腺癌细胞对比卡鲁胺敏感。
Prostate. 2008 May 15;68(7):793-801. doi: 10.1002/pros.20748.
8
Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.类固醇生成酶 AKR1C3 是一种新型的雄激素受体选择性共激活剂,可促进前列腺癌生长。
Clin Cancer Res. 2013 Oct 15;19(20):5613-25. doi: 10.1158/1078-0432.CCR-13-1151. Epub 2013 Aug 30.
9
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor.比卡鲁胺通过组装转录无活性受体发挥雄激素受体拮抗剂的作用。
J Biol Chem. 2002 Jul 19;277(29):26321-6. doi: 10.1074/jbc.M203310200. Epub 2002 May 15.
10
Influence of short polyglutamine tracts and p160 coactivators on the transactivation of the androgen receptor.短聚谷氨酰胺重复序列和 p160 共激活因子对雄激素受体转录激活的影响。
Cancer Biother Radiopharm. 2011 Apr;26(2):191-201. doi: 10.1089/cbr.2010.0888.

引用本文的文献

1
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.鉴定破坏雄激素受体共激活蛋白-蛋白相互作用从而改变反式激活的变构调节剂-用于转移性去势抵抗性前列腺癌的药物先导物。
SLAS Discov. 2023 Oct;28(7):325-343. doi: 10.1016/j.slasd.2023.08.001. Epub 2023 Aug 6.
2
Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.用于探究化合物抑制雄激素受体AF-2或AF-1反式激活结构域能力的检测方法。
Assay Drug Dev Technol. 2019 Nov/Dec;17(8):364-386. doi: 10.1089/adt.2019.940. Epub 2019 Sep 6.
3
High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.
用于鉴定抑制或破坏雄激素受体-转录中介因子2蛋白质-蛋白质相互作用以治疗前列腺癌的化合物的高内涵筛选活动。
Assay Drug Dev Technol. 2018 Aug/Sep;16(6):297-319. doi: 10.1089/adt.2018.858. Epub 2018 Aug 15.
4
High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.用于筛选预防或破坏雄激素受体与转录中介因子2蛋白-蛋白相互作用的化合物的高内涵定位生物传感器分析
Methods Mol Biol. 2018;1683:211-227. doi: 10.1007/978-1-4939-7357-6_13.
5
Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.在前列腺癌细胞中重新配置AR-TIF2蛋白质-蛋白质相互作用的高内涵筛选分析,并对LOPAC筛选得到的命中结果进行表征。
Assay Drug Dev Technol. 2016 Oct;14(8):453-477. doi: 10.1089/adt.2016.741. Epub 2016 Sep 8.
6
Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential.前列腺肿瘤细胞对外源性雄激素依赖性的丧失与葡萄糖醛酸化潜力升高有关。
Horm Cancer. 2016 Aug;7(4):260-71. doi: 10.1007/s12672-016-0268-z. Epub 2016 Jun 15.
7
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.雄激素受体与PI3K的相互反馈抑制作为去势敏感性和去势抵抗性前列腺癌的一种新疗法。
Oncotarget. 2015 Dec 8;6(39):41976-87. doi: 10.18632/oncotarget.5659.
8
High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.用于筛选预防或破坏雄激素受体与转录中介因子2蛋白质-蛋白质相互作用的化合物的高内涵定位生物传感器检测法。
Assay Drug Dev Technol. 2014 Sep;12(7):395-418. doi: 10.1089/adt.2014.594.
9
Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer.不断变化的多西他赛耐药性去势抵抗性前列腺癌的治疗标准。
Prostate Cancer Prostatic Dis. 2011 Sep;14(3):192-205. doi: 10.1038/pcan.2011.23. Epub 2011 May 17.
10
Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.雄激素受体及其相关赖氨酸去甲基酶共激活因子 LSD1 和 JMJD2A 在局部和晚期人膀胱癌中的作用。
Mol Carcinog. 2011 Dec;50(12):931-44. doi: 10.1002/mc.20758. Epub 2011 Mar 11.